Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management

By B. Spellberg, J. Edwards, A. Ibrahim. Clinical Microbiology Reviews, 2005

1,367 citations recorded by the source corpus.

Subfields: Epidemiology, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/46066da6cf913f1a34f85917523a50e5a1603719

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. T. Walsh
2. A. Ibrahim
3. B. Spellberg
4. D. Kontoyiannis

In Infectious Diseases

1. D. Kontoyiannis

Citations in the corpus

• Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. (2011, background): “However, the exact pathogenesis leading to the association between diabetes and rhinocerebral disease is not clear [20].”
• Epidemiology and clinical manifestations of mucormycosis. (2012, background): “The majority of human cases are caused by Mucorales fungi; therefore, the terms mucormycosis and zygomycosis are used interchangeably (the term phycomycosis is also used) [1, 2].”
• Pathogenesis of mucormycosis. (2012, background): “Mucormycosis infections are characterized by extensive angioinvasion that results in vessel thrombosis and subsequent tissue necrosis [3, 6, 43].”